Brief: Neuropace Files Pma Supplement To FDA
17/12/2025 13:25
Dec 17 (Reuters) - Neuropace Inc NPCE.O: NEUROPACE FILES PMA SUPPLEMENT TO FDA SEEKING EXPANDED RNS® SYSTEM INDICATION FOR IDIOPATHIC GENERALIZED EPILEPSY Source text: ID:nBw7PrvK2a Further company coverage: NPCE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuroPace
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
NeuroPace, Inc. reports results for the quarter ended June 30 - Earnings Summary
NeuroPace Q2 revenue slightly beats estimates
Brief: NeuroPace, Inc. Q2 EPS USD -0.18
NeuroPace, Inc. expected to post a loss of 21 cents a share - Earnings Preview